David Risinger Score: 36
Analyst at
Leerink Partners,
New Street
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+13.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
72%
18 W / 7 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
67%
10 W / 5 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
7%
1 W / 14 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 15 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
58%
7 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
67%
14 W / 7 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
4 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| May 26, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,119.00
Est. +5%
|
$1,065.00 | $1,182.73 |
Target Met
|
$1,133.00
+6.4%
|
| May 21, 2026 |
Roivant Sciences Ltd
ROIV
|
BUY |
$42.00
Est. +30%
|
$32.41 | $32.71 |
Pending
|
$30.04
-7.3%
|
| May 13, 2026 |
Johnson & Johnson
JNJ
|
BUY |
$265.00
Est. +18%
|
$224.26 | $241.60 |
Pending
|
$240.87
+7.4%
|
| Mar 05, 2026 |
AMGEN Inc.
AMGN
|
SELL |
$355.00
Est. +3%
|
$367.60 | $320.53 (Low) |
Target Met
|
$355.20
+3.4%
|
| Jan 13, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$60.00
Est. +6%
|
$56.39 | $62.89 |
Target Met
|
$57.13
+1.3%
|
| Jan 05, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,234.00
Est. +14%
|
$1,080.36 | $1,182.73 |
Pending
|
$1,133.00
+4.9%
|
| Dec 15, 2025 |
Roivant Sciences Ltd
ROIV
|
BUY |
$32.00
Est. +45%
|
$22.10 | $32.79 |
Precision Hit (±3%)
|
$30.04
+35.9%
|
| Dec 11, 2025 |
XOMA Royalty Corp.
XOMA
|
BUY |
$45.00
Est. +70%
|
$26.51 | $42.81 |
Pending
|
$41.79
+57.6%
|
| Nov 19, 2025 |
Vaxcyte Inc
PCVX
|
BUY |
$77.00
Est. +55%
|
$49.53 | $64.79 |
Pending
|
$47.46
-4.2%
|
| Nov 11, 2025 |
Roivant Sciences Ltd
ROIV
|
BUY |
$29.00
Est. +37%
|
$21.17 | $32.79 |
Target Met
|
$30.04
+41.9%
|
| Jul 14, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$114.00
Est. +2%
|
$112.09 | $157.27 |
Target Met
|
$125.59
+12.0%
|
| Nov 13, 2024 |
Theravance Biopharma Inc
TBPH
|
BUY |
$10.00
Est. +31%
|
$7.66 | $18.96 |
Target Met
|
$16.64
+117.2%
|
| Nov 06, 2024 |
AnaptysBio Inc
ANAB
|
BUY |
$45.00
Est. +132%
|
$19.38 | $27.31 |
Miss
|
$56.07
+189.3%
|
| Nov 06, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$135.00
Est. +26%
|
$106.74 | $116.00 |
Miss
|
$47.46
-55.5%
|
| Oct 21, 2024 |
Roivant Sciences Ltd
ROIV
|
BUY |
$17.00
Est. +43%
|
$11.92 | $18.06 |
Target Met
|
$30.04
+152.0%
|
| Oct 03, 2024 |
AnaptysBio Inc
ANAB
|
SELL |
$35.00
Est. +1%
|
$35.22 | $8.14 (Low) |
Target Met
|
$56.07
-59.2%
|
| Sep 24, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$1,077.00
Est. +1%
|
$1,091.98 | $476.49 (Low) |
Target Met
|
$612.14
+43.9%
|
| Sep 03, 2024 |
Vaxcyte Inc
PCVX
|
BUY |
$153.00
Est. +37%
|
$112.04 | $121.06 |
Miss
|
$47.46
-57.6%
|
| Apr 16, 2024 |
AnaptysBio Inc
ANAB
|
BUY |
$47.00
Est. +121%
|
$21.27 | $27.54 |
Miss
|
$56.07
+163.6%
|
| Oct 12, 2023 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$66.00
Est. +17%
|
$56.25 | $54.54 |
Miss
|
$57.13
+1.6%
|
| May 25, 2022 |
HilleVax Inc
HLVX
|
BUY |
$30.00
Est. +197%
|
$10.11 | - | - |
$2.09
-79.3%
|
| May 24, 2022 |
Abbvie Inc
ABBV
|
SELL |
$140.00
Est. +5%
|
$148.03 | - | - |
$227.73
-53.8%
|
| May 23, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$341.00
Est. +13%
|
$302.76 | - | - |
$1,133.00
+274.2%
|
| May 23, 2022 |
Gilead Sciences, Inc.
GILD
|
BUY |
$68.00
Est. +6%
|
$64.04 | - | - |
$125.59
+96.1%
|
| May 23, 2022 |
Pfizer Inc.
PFE
|
BUY |
$55.00
Est. +4%
|
$52.88 | - | - |
$26.21
-50.4%
|
Lilly(Eli) & Co
LLY
May 26, 2026
Signal & Target
BUY
$1,119.00
Start Price
$1,065.00
Best Price (1Y)
$1,182.73
Current Price
$1,133.00
Return
+6.4%
Roivant Sciences Ltd
ROIV
May 21, 2026
Signal & Target
BUY
$42.00
Start Price
$32.41
Best Price (1Y)
$32.71
Current Price
$30.04
Return
-7.3%
Johnson & Johnson
JNJ
May 13, 2026
Signal & Target
BUY
$265.00
Start Price
$224.26
Best Price (1Y)
$241.60
Current Price
$240.87
Return
+7.4%
AMGEN Inc.
AMGN
Mar 05, 2026
Signal & Target
SELL
$355.00
Start Price
$367.60
Best Price (1Y)
$320.53
Current Price
$355.20
Return
+3.4%
Bristol-Myers Squibb Co.
BMY
Jan 13, 2026
Signal & Target
BUY
$60.00
Start Price
$56.39
Best Price (1Y)
$62.89
Current Price
$57.13
Return
+1.3%
Lilly(Eli) & Co
LLY
Jan 05, 2026
Signal & Target
BUY
$1,234.00
Start Price
$1,080.36
Best Price (1Y)
$1,182.73
Current Price
$1,133.00
Return
+4.9%
Roivant Sciences Ltd
ROIV
Dec 15, 2025
Signal & Target
BUY
$32.00
Start Price
$22.10
Best Price (1Y)
$32.79
Current Price
$30.04
Return
+35.9%
XOMA Royalty Corp.
XOMA
Dec 11, 2025
Signal & Target
BUY
$45.00
Start Price
$26.51
Best Price (1Y)
$42.81
Current Price
$41.79
Return
+57.6%
Vaxcyte Inc
PCVX
Nov 19, 2025
Signal & Target
BUY
$77.00
Start Price
$49.53
Best Price (1Y)
$64.79
Current Price
$47.46
Return
-4.2%
Roivant Sciences Ltd
ROIV
Nov 11, 2025
Signal & Target
BUY
$29.00
Start Price
$21.17
Best Price (1Y)
$32.79
Current Price
$30.04
Return
+41.9%
Gilead Sciences, Inc.
GILD
Jul 14, 2025
Signal & Target
BUY
$114.00
Start Price
$112.09
Best Price (1Y)
$157.27
Current Price
$125.59
Return
+12.0%
Theravance Biopharma Inc
TBPH
Nov 13, 2024
Signal & Target
BUY
$10.00
Start Price
$7.66
Best Price (1Y)
$18.96
Current Price
$16.64
Return
+117.2%
AnaptysBio Inc
ANAB
Nov 06, 2024
Signal & Target
BUY
$45.00
Start Price
$19.38
Best Price (1Y)
$27.31
Current Price
$56.07
Return
+189.3%
Vaxcyte Inc
PCVX
Nov 06, 2024
Signal & Target
BUY
$135.00
Start Price
$106.74
Best Price (1Y)
$116.00
Current Price
$47.46
Return
-55.5%
Roivant Sciences Ltd
ROIV
Oct 21, 2024
Signal & Target
BUY
$17.00
Start Price
$11.92
Best Price (1Y)
$18.06
Current Price
$30.04
Return
+152.0%
AnaptysBio Inc
ANAB
Oct 03, 2024
Signal & Target
SELL
$35.00
Start Price
$35.22
Best Price (1Y)
$8.14
Current Price
$56.07
Return
-59.2%
Regeneron Pharmaceuticals, Inc.
REGN
Sep 24, 2024
Signal & Target
SELL
$1,077.00
Start Price
$1,091.98
Best Price (1Y)
$476.49
Current Price
$612.14
Return
+43.9%
Vaxcyte Inc
PCVX
Sep 03, 2024
Signal & Target
BUY
$153.00
Start Price
$112.04
Best Price (1Y)
$121.06
Current Price
$47.46
Return
-57.6%
AnaptysBio Inc
ANAB
Apr 16, 2024
Signal & Target
BUY
$47.00
Start Price
$21.27
Best Price (1Y)
$27.54
Current Price
$56.07
Return
+163.6%
Bristol-Myers Squibb Co.
BMY
Oct 12, 2023
Signal & Target
BUY
$66.00
Start Price
$56.25
Best Price (1Y)
$54.54
Current Price
$57.13
Return
+1.6%
HilleVax Inc
HLVX
May 25, 2022
Signal & Target
BUY
$30.00
Start Price
$10.11
Best Price (1Y)
-
Current Price
$2.09
Return
-79.3%
Abbvie Inc
ABBV
May 24, 2022
Signal & Target
SELL
$140.00
Start Price
$148.03
Best Price (1Y)
-
Current Price
$227.73
Return
-53.8%
Lilly(Eli) & Co
LLY
May 23, 2022
Signal & Target
BUY
$341.00
Start Price
$302.76
Best Price (1Y)
-
Current Price
$1,133.00
Return
+274.2%
Gilead Sciences, Inc.
GILD
May 23, 2022
Signal & Target
BUY
$68.00
Start Price
$64.04
Best Price (1Y)
-
Current Price
$125.59
Return
+96.1%
Pfizer Inc.
PFE
May 23, 2022
Signal & Target
BUY
$55.00
Start Price
$52.88
Best Price (1Y)
-
Current Price
$26.21
Return
-50.4%